China Pioneer Pharma Holdings Limited (SEHK:1345) commences share repurchases on September 20, 2017, under the program mandated by the shareholders in the Annual General Meeting held on April 28, 2017. As per the mandate, the company is authorized to repurchase up to 133,333,400 shares, representing 10% of its issued share capital. Any repurchase will be made out of funds which are legally available for the purpose. The repurchases will lead to an enhancement of the net assets and/or its earnings per share. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual general Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As of April 28, 2017, the company had 1,333,334,000 shares in issue.